Pharmaceutical Business Review report “Baxter Corporation is investing $10m to build a new facility in Mississauga, Ontario for its Centralized Intravenous Admixing Pharmacy Service (CIVA). Triple the size of the current facility, the new Baxter CIVA Pharmacy Service will expand Baxter’s ability to meet the needs of Canadian hospitals, clinics and other care facilities for ready-to-administer intravenous (IV) admixtures including chemotherapy, high alert medications and anti-infectives, enabling pharmacists to focus on more direct patient care and clinical activities.
Baxter to build new intravenous admixing facility in Canada http://ctt.ec/M5qua+ @ivteam #ivteam
Baxter’s new CIVA facility will double its number of clean rooms available to support customized requirements for hazardous and non-hazardous IV admixing and the company anticipates expanding the workforce by approximately 25 positions over the next few years. Additionally, the new CIVA will include a new training facility through which Baxter will partner with professional organizations, academia, and hospital pharmacists and technicians to support their certification requirements and help maintain their skillset in IV admixing. The company expects to open and transition operations to its new CIVA facility in October 2015.Full Story
Thank you to our partners for supporting IVTEAM